GE goes to market with new MRI co-designed with the NFL

GE Healthcare has won FDA 510(k) clearance to sell a 3-T MRI system developed with input from several neuroimaging research institutions as well as the National Football League.

The wide- yet short-bore system, called Signa Premier, has been in the works for four years and incorporates technology designed to detect biomarkers of concussion and other forms of mild traumatic brain injury, according to a press release.

GE says the system includes digital radiofrequency transmit-and-receive architecture, enabling imagers to acquire patient data from multiple high channel-density surface coils all at once.

Eric Stahre, PhD, president and CEO of the company’s global MRI operation, says the new system “will help clinicians push the boundaries of what’s possible with MR.”

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.